Skip to main content

Behavioral Effects of Anticholinergic Psychotomimetics and Their Antagonists in Man and Animals

  • Chapter

Abstract

Although it appears clear that several types of neurohumoral transmission systems are involved in the central nervous system, little is known concerning their relative roles in controlling central and peripheral activities. Gross changes in the levels of any one of these substances have been reported to produce changes in behavior [8,4,27]. How these systems are affected and interrelated in mental disease is even less clearly understood.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bell, C., and Gershon, S.: Experimental Anticholinergic Psychotomimetics. Antagonism of Yohimbine and Tacrine (THA), Med. Exper. 10: 15–21, 1964.

    CAS  Google Scholar 

  2. Bell, C., Gershon, S., Carroll, B., and Holan, G.: Behavioral Antagonism to a New Psychotomimetic: JB-329, Arch. Intern. Pharmacodyn. Therap. 147: 9–25, 1964.

    CAS  Google Scholar 

  3. Bender, L.: A Visual Motor Gestalt Test and Its Clinical Use, Research Monograph No. 3, American Orthopsychiatric Association, New York, 1938.

    Google Scholar 

  4. Brodie, B. B., and Shore, P. A.: A Concept for a Role of Serotonin and Norepinephrine as Chemical Mediators in the Brain, Ann. N. Y. Acad. Sci. 66: 631–642, 1957.

    Article  PubMed  CAS  Google Scholar 

  5. Delay, J., Deniker, P., Verdeaux, G., Ginestet, D., and Peron, P.: Intérnt des commies cliniques et polygraphiques simultanés pour l’évaluation précoce de l’activité de certaines drogues chez l’homme, Neuropsychopharmacology 3: 1962.

    Google Scholar 

  6. (Fazio, C.) Giberti, F., Roccatagliata, G., and Rossi, R.: Study of the Neurological Effects and of the Psychopathological Action of a New Drug with Psychotomimetic Action (JB 329 or Ditran) in Depressed Patients, Sistema Nervoso, No. 3: 167–175, 1961.

    Google Scholar 

  7. Feldberg, W.: Animal Behavior and Drug Action, Ciba Foundation, Reuck and Knight (eds.), Little, Brown and Company, Boston, 1964, pp. 429–433.

    Google Scholar 

  8. Feldberg, W., and Sherwood, S.: Behavior of Cats after Intraventricular Injections of Eserine and DFP, J. Physiol. 125: 488–500, 1954.

    PubMed  CAS  Google Scholar 

  9. Finkelstein, B. A.: Ditran: A Psychotherapeutic Advance, J. Neuropsychiat. 2: 144–148, 1961.

    PubMed  CAS  Google Scholar 

  10. Gershon, S.: Blocking Effect of Tetrahydroaminacrin on a New Psychotomimetic Agent, Nature 186: 1072–1073, 1960.

    Article  PubMed  CAS  Google Scholar 

  11. Gershon, S., and Lang, W.: A Psychopharmacological Study of Some Indole Alkaloids, Arch. Intern. Pharmacodyn. Therap. 135: 31–56, 1962.

    CAS  Google Scholar 

  12. Gershon, S., and Olariu, J.: JE-329-A New Psychotomimetic-Its Antagonism by Tetrahydroaminacrin and Its Comparison with LSD, Mescaline, and Sernyl, J. Neuropsychiat. 1: 283–292, 1960.

    PubMed  CAS  Google Scholar 

  13. Gershon, S., and Shaw, F. H.: Psychiatric Sequelae of Chronic Exposure to Organophosphorus Insecticides, Lancet, June 24: 1371–1374, 1961.

    Article  Google Scholar 

  14. Goldenberg, M. A.: Induction of Certain Symptoms of Atropine Psychosis in Animals and Their Significance, Novosebersk. Govt. Med. Inst. Publ. 29: 7, 1957.

    Google Scholar 

  15. Greig, M. E., and Gibbons, A. J.: Effect of Various Psychotomimetic Drugs on Rate of Appearance of Carbon-14 in the Brains of Mice after Administration of C-14 Glucose, Am. J. Physiol. 196: 803–806, 1959.

    PubMed  CAS  Google Scholar 

  16. Grob, D., Lilienthal, J. L., Jr., Harvey, A.M., and Jones, B. F.: Administration of Di-isopropyl Fluorophosphate (DFP) to Man. I. Effect on Plasma Erythrocyte Cholinesterase: General Systemic Effects, Bull. Johns Hopkins Hosp. 81: 217–244, 1947.

    Google Scholar 

  17. Grob, D., Harvey, A. M., Langworthy, O. R., and Lilienthal, J. L., Jr.: Administration of Di-isopropyl Fluorophosphate (DFP) to Man. III. Effect on Central Nervous System with Special Reference to the Electrical Activity of the Brain, Bull. Johns Hopkins Hosp. 81: 257–266, 1947.

    PubMed  CAS  Google Scholar 

  18. Grob, D., Garlick, W. L., and Harvey, A. M.: Toxic Effects in Man of Anticholinesterase Insecticide Parathion (p-Nitrophenyl Diethyl Thionophosphate), Bull. Johns Hopkins Hosp. 87: 106–129, 1950.

    PubMed  CAS  Google Scholar 

  19. Horowitz, Z. P., and Chow, M. I.: Effect of Centrally Active Drugs on the Correlation of Electrocortical Activity and Wakefulness of Cats, J. Pharmacol. Exper. Therap. 137: 127–132, 1962.

    Google Scholar 

  20. Lakeside Laboratories, Inc.: Preclinical and clinical information brochure.

    Google Scholar 

  21. Lebovits, B.Z., Visotsky, H. M., and Ostfeld, A.M.: LSD and JB-318: Comparison of Two Hallucinogens, Arch. Gen. Psychiat. 7: 39–45, 1962.

    Article  CAS  Google Scholar 

  22. Leslie, G. B., and Maxwell, D. R.: Some Pharmacological Properties of Thioproperazine and Their Modification by Anti-Parkinsonian Drugs, Brit. J. Pharmacol. 22: 301–317, 1964.

    CAS  Google Scholar 

  23. Meduna, L. J., and Abood, L. G.: Studies of a New Drug (Ditran) in Depressive States, J. Neuropsychiat. 1: 20–22, 1959.

    Google Scholar 

  24. Morpurgo, C.: Effects of Anti-Parkinsonian Drugs one Phenothiazine-Induced Catatonic Reaction, Arch. Intern. Pharmacodyn. Therap. 134: 84–90, 1962.

    Google Scholar 

  25. Neubauer, H., Sundland, D., and Gershon, S.: Ditran and Its Antagonists in a Mixed Psychiatric Population, J. Nervous Mental Disease (in press).

    Google Scholar 

  26. Proctor, C. D., Ridlon, S. A., Fudema, J. J., and Prabhu, V. G.: Extension of Tranquilizer Action by Anticholinesterases, Toxicol. Appl. Pharmacol. 6: 1–8, 1964.

    Article  CAS  Google Scholar 

  27. Rowntree, D. W., Nevin, S., and Wilson, A.: Effects of Di-isopropyl Fluorophosphonate in Schizophrenia and Manic Depressive Psychosis, J. Neurol. Neurosurg. Psychiat. 13: 47–62, 1950.

    Article  PubMed  CAS  Google Scholar 

  28. Sherwood, S.: Intraventricular Medication in Catatonic Stupor (prelim. comm.), Brain 75: 68–75, 1952.

    Article  PubMed  CAS  Google Scholar 

  29. Siegel, S.: Nonparametric Statistics, New York, 1956, McGraw-Hill Book Company.

    Google Scholar 

  30. Wikler, A.: The Relation of Psychiatry to Pharmacology, American Society for Pharmacology and Experimental Therapeutics, Baltimore, 1957, The Williams amp; Wilkins Co.

    Google Scholar 

  31. Wilson, R. E., and Shagass, C.: Comparison of Two Drugs with Psychotomimetic Effects (LSD and Ditran), J. Nervous Mental Disease 138: 277–286, 1964.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1966 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gershon, S. (1966). Behavioral Effects of Anticholinergic Psychotomimetics and Their Antagonists in Man and Animals. In: Wortis, J. (eds) Recent Advances in Biological Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7313-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7313-9_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7298-9

  • Online ISBN: 978-1-4899-7313-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics